Table 1.
Results of amplified fragment length polymorphism in PRA-affected and control ESDs.
| Disease Status | Homozygous SINE +/+ |
Heterozygous SINE +/- |
Homozygous Wild-Type -/- |
Total |
|---|---|---|---|---|
| PRA-Affected | 6 | 0 | 0 | 6 |
| Clear | 0 | 6 | 14 | 20 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.